Arzerra ofatumumab regulatory update

Genmab A/S (CSE:GEN), Copenhagen, Denmark GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Arzerra ofatumumab ( HuMax-CD20) Business: Cancer FDA's Oncologic Drugs Advisory Committee vo...